John R. Cardinal

1.7k total citations
26 papers, 1.2k citations indexed

About

John R. Cardinal is a scholar working on Pharmaceutical Science, Organic Chemistry and Molecular Biology. According to data from OpenAlex, John R. Cardinal has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 8 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in John R. Cardinal's work include Drug Solubulity and Delivery Systems (10 papers), Surfactants and Colloidal Systems (7 papers) and Advanced Drug Delivery Systems (4 papers). John R. Cardinal is often cited by papers focused on Drug Solubulity and Delivery Systems (10 papers), Surfactants and Colloidal Systems (7 papers) and Advanced Drug Delivery Systems (4 papers). John R. Cardinal collaborates with scholars based in United States. John R. Cardinal's co-authors include Pasupati Mukerjee, Gaylen M. Zentner, K.L. Smith, Scott M. Herbig, Avinash G. Thombre, Richard W. Korsmeyer, Sung Wan Kim, Mark B. McKeough, Spotswood L. Spruance and S.W. Kim and has published in prestigious journals such as Advanced Drug Delivery Reviews, The Journal of Physical Chemistry and Journal of Controlled Release.

In The Last Decade

John R. Cardinal

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Cardinal United States 15 451 351 220 195 166 26 1.2k
Lars‐Olof Sundelöf Sweden 24 540 1.2× 148 0.4× 172 0.8× 197 1.0× 228 1.4× 68 1.2k
M. Donbrow Israel 22 425 0.9× 822 2.3× 208 0.9× 170 0.9× 49 0.3× 70 1.6k
Johan Carlfors Sweden 23 297 0.7× 753 2.1× 261 1.2× 363 1.9× 56 0.3× 29 1.6k
Kyrre Thalberg Sweden 22 712 1.6× 177 0.5× 94 0.4× 99 0.5× 409 2.5× 50 1.7k
Krister Thuresson Sweden 32 1.5k 3.3× 312 0.9× 177 0.8× 195 1.0× 447 2.7× 63 2.5k
Stefan Nilsson Sweden 20 364 0.8× 74 0.2× 328 1.5× 282 1.4× 132 0.8× 30 902
T.J. Roseman United States 16 338 0.7× 728 2.1× 261 1.2× 223 1.1× 43 0.3× 33 1.6k
B. Lippold Germany 25 227 0.5× 947 2.7× 89 0.4× 150 0.8× 23 0.1× 94 1.9k
Delfi Bastos‐González Spain 26 413 0.9× 454 1.3× 87 0.4× 431 2.2× 448 2.7× 40 2.3k
P. Claes Belgium 21 459 1.0× 46 0.1× 113 0.5× 110 0.6× 94 0.6× 138 1.6k

Countries citing papers authored by John R. Cardinal

Since Specialization
Citations

This map shows the geographic impact of John R. Cardinal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Cardinal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Cardinal more than expected).

Fields of papers citing papers by John R. Cardinal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Cardinal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Cardinal. The network helps show where John R. Cardinal may publish in the future.

Co-authorship network of co-authors of John R. Cardinal

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Cardinal. A scholar is included among the top collaborators of John R. Cardinal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Cardinal. John R. Cardinal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thombre, Avinash G., et al.. (1999). Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. Journal of Controlled Release. 57(1). 65–73. 53 indexed citations
2.
Thombre, Avinash G., et al.. (1999). Asymmetric membrane capsules for osmotic drug delivery. Journal of Controlled Release. 57(1). 55–64. 75 indexed citations
3.
Cardinal, John R., et al.. (1997). The in vitro and in vivo performance of an osmotically controlled delivery system — IVOMEC SR®1®Registered Trademark of Merck and Co.1 bolus. Journal of Controlled Release. 47(1). 1–11. 14 indexed citations
4.
Thombre, Avinash G., et al.. (1992). A delivery device containing a poorly water-soluble drug in a hydrophobic medium: ruminal delivery application. Journal of Controlled Release. 18(3). 221–233. 3 indexed citations
5.
Giardino, Angela, et al.. (1988). Perforated Coated Tablets for Controlled Release of Drugs at a Constant Rate. Journal of Pharmaceutical Sciences. 77(4). 322–324. 22 indexed citations
6.
Aguiar, Armando J., et al.. (1988). The morantel sustained release trilaminate: A device for the controlled ruminal delivery of morantel to cattle. Journal of Controlled Release. 8(1). 23–30. 22 indexed citations
7.
Berenson, Malcolm M. & John R. Cardinal. (1985). Calcium accelerates cholesterol phase transitions in analog bile. Cellular and Molecular Life Sciences. 41(10). 1328–1330. 8 indexed citations
8.
Spruance, Spotswood L., Mark B. McKeough, & John R. Cardinal. (1984). Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrobial Agents and Chemotherapy. 25(1). 10–15. 52 indexed citations
9.
Spruance, Spotswood L., Mark B. McKeough, & John R. Cardinal. (1983). DIMETHYL SULFOXIDE AS A VEHICLE FOR TOPICAL ANTIVIRAL CHEMOTHERAPY*. Annals of the New York Academy of Sciences. 411(1). 28–33. 11 indexed citations
10.
Zentner, Gaylen M., John R. Cardinal, & S.W. Kim. (1981). Free fatty acid-induced platelet aggregation: Studies with solubilized and nonsolubilized fatty acids. Journal of Pharmaceutical Sciences. 70(9). 975–981. 4 indexed citations
11.
Kim, S.W., et al.. (1980). Drug release from hydrogel devices with ratecontrolling barriers. Journal of Membrane Science. 7(3). 293–303. 101 indexed citations
12.
Zentner, Gaylen M., et al.. (1979). Progestin Permeation through Polymer Membranes IV: Mechanism of Steroid Permeation and Functional Group Contributions to Diffusion through Hydrogel Films. Journal of Pharmaceutical Sciences. 68(8). 970–975. 51 indexed citations
13.
Zentner, Gaylen M., John R. Cardinal, & D. E. Gregonis. (1979). Progestin Permeation Through Polymer Membranes III: Polymerization Solvent Effect on Progesterone Permeation Through Hydrogel Membranes. Journal of Pharmaceutical Sciences. 68(6). 794–795. 9 indexed citations
14.
Zentner, Gaylen M., John R. Cardinal, & Sung Wan Kim. (1978). Progestin Permeation through Polymer Membranes I: Diffusion Studies on Plasma-Soaked Membranes. Journal of Pharmaceutical Sciences. 67(10). 1347–1351. 33 indexed citations
15.
Cardinal, John R., et al.. (1978). Solubilization of Naphthalene by Sodium Cholate and Pattern of Self- Association of Sodium Cholate in 0.15M Sodium Chloride. Journal of Pharmaceutical Sciences. 67(6). 854–856. 10 indexed citations
16.
17.
18.
Cardinal, John R., et al.. (1978). Effect of potassium on proximal tubular function. American Journal of Physiology-Renal Physiology. 234(5). F381–F385. 13 indexed citations
19.
Zentner, Gaylen M., John R. Cardinal, & Sung Wan Kim. (1978). Progestin Permeation through Polymer Membranes II: Diffusion Studies on Hydrogel Membranes. Journal of Pharmaceutical Sciences. 67(10). 1352–1355. 45 indexed citations
20.
Mukerjee, Pasupati & John R. Cardinal. (1976). Solubilization as a method for studying self-association: Solubility of naphthalene in the bile salt sodium cholate and the complex pattern of its aggregation. Journal of Pharmaceutical Sciences. 65(6). 882–886. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars‐Olof Sundelöf Breakdown of academic impact, for papers by M. Donbrow Breakdown of academic impact, for papers by Johan Carlfors Breakdown of academic impact, for papers by Kyrre Thalberg Breakdown of academic impact, for papers by Krister Thuresson Breakdown of academic impact, for papers by Stefan Nilsson Breakdown of academic impact, for papers by T.J. Roseman Breakdown of academic impact, for papers by B. Lippold Breakdown of academic impact, for papers by Delfi Bastos‐González Breakdown of academic impact, for papers by P. Claes
Rankless by CCL
2026